ARRAY BIOPHARMA INC — Form D/A
ARRAY BIOPHARMA INC of BOULDER, CO, a company, filed a Form D amendment with the SEC on 2009-08-12. Industry: Biotechnology.
Offering
- Filed: 2009-08-12
- Form: D/A
- Accession: 0001123292-09-000700
- Industry: Biotechnology
- Exemptions: 06
- Investors: 2
- Date of first sale: 2009-05-15
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-118338
Issuer
- Name: ARRAY BIOPHARMA INC
- CIK: 0001100412
- Entity type: Corporation
- Jurisdiction: DE
- Address: 3200 WALNUT STREET, BOULDER, CO, 80301
- Phone: 3033816600
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Francis J Bullock | Director | Boulder, CO |
| Marvin H Caruthers | Director | Boulder, CO |
| Robert E Conway | Director | Westminster, CO |
| KEVIN KOCH | Director | WOBURN, MA |
| Kyle A Lefkoff | Director | Boulder, CO |
| David Snitnam | Director | Boulder, CO |
| Gil J Van Lunsen | Director | Boulder, CO |
| Douglas E Williams | Director | New York, NY |
| John L Zabriskie | Director | Broomfield, CO |
| R. Michael Carruthers | Executive Officer | Boulder, CO |
| Robert E Conway | Executive Officer | Westminster, CO |
| KEVIN KOCH | Executive Officer | WOBURN, MA |
| John R Moore | Executive Officer | Boulder, CO |
| David Snitnam | Executive Officer | Boulder, CO |
Other filings by this issuer (1)
More